Abstract
We recorded cardiovascular responses to serotonin (5- HT) and to two selective serotonergic agonists following ketanserin treatment in 3 groups of conscious rats aged 4, 14 or 24 months. The selective agonists were DOI (5- HT2 agonist), and phenylbiguanide (5- HT3 agonist). Before ketanserin treatment, pressor responses to 5- HT or DOI were larger while reflex bradycardic responses to 5- HT or phenylbiguanide were smaller in 14- and 24- month than in 4- month- old rats. Ketanserin treatment lowered blood pressure consistently, and the ensuing hypotension was more pronounced in 14- and 24- month than in 4- month- old rats. Pressor responses to DOI were attenuated similarly in all rats, but those to 5- HT were reversed to depressor responses whose magnitude was smaller in 14- and 24- month than in 4- month- old rats. On the other hand, bradycardic responses to 5- HT and phenylbiguanide were enhanced in 14- and 24- but not in 4- month- old rats. Our results indicate that even before ketanserin was given, old rats had enhanced pressor responses to 5- HT2 agonists together with weakened bradycardic responses to 5- HT3 agonists. Following ketanserin treatment, 5- HT2 pressor responses were blocked while 5- HT3 bradycardic responses were enhanced but only in old rats. These results are compatible with the interpretation that the more pronounced hypotension produced in old rats by ketanserin is due to two complementary effects on serotonergic receptors: blockade of 5- HT2 pressor responses coupled with selective enhancement of 5- HT3 bradycardic responses. (Aging Clin. Exp. Res. 6: 239–248, 1994)
Similar content being viewed by others
References
De Crée J., Houig M., De Ryck M., Symoens J.: The acute antihypertensive effect of ketanserin increases with age. J. Cardiovasc. Pharmacol 7: S126–S127, 1985.
Rosendorff C., Murray G.D.: Ketanserin versus metoprolol and hydrochlorothiazide in essential hypertension: only ketanserin’s effect is age-related. J. Hypertens. 4: S109–S111, 1986.
Leysen J.E., Awouters F., Kenis L., Laduron P.M., Vanderberk J., Janssen P.A.J.: Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. Life Sci. 28: 1015–1022, 1981.
Strokes G.S.: Age-related effects of antihypertensive therapy with α-blockers. J. Cardiovasc. Pharmacol. 12: S109–S115, 1988.
Klein C., Gerber J.C., Payne N.A., Nies A.S.: The effect of age on the sensitivity of the α1-adrenoceptor to phenylephrine and prazosin. Clin. Pharmacol. Ther. 47: 535–539, 1990.
Pettersson A., Gradin K., Hedner T., Henning M., Persson B.: Chronic serotonergic blockade with ketanserin in the spontaneously hypertensive rat. J. Cardiovasc. Pharmacol. 7: S112–S113, 1985.
Balasubramaniam G., Lee H.S., Mah S.C.: Differences in the acute and chronic antihypertensive mechanism of action of ketanserin in spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 264: 129–134, 1993.
Wenting G.J., Woittiez A.J., Man in’t Veld A.J., Schalekamp M.A.: 5HT, alpha-adrenoceptors and blood pressure effects of ketanserin in essential hypertension and autonomic insufficiency. Hypertension 6: 100–109, 1984.
Nyborg N.C.B., Mikkelsen E.O.: Serotonin response increases with age in rat coronary resistance arteries. Cardiouasc. Res. 22: 131–137, 1988.
Toda N., Hayashi S.: Age dependent alteration in the response of isolated rabbit basilar arteries to vasoactive agents. J. Pharmacol Exp. Ther. 211: 716–721, 1979.
Hayashi S., Toda N.: Age related changes in the response of rabbit isolated aortae to vasoactive agents. Br. J. Pharmacol 64: 229–237, 1978.
Blackshear J.L., Orlandi C., Granic J.D., Hollenberg N.K.: Differential large and small vessel responses to serotonin in the dog hindlimb in vivo. Role of the 5-HT2 receptor. J. Cardiovasc. Pharmacol 7: 42–49, 1985.
Blauw G.J., van Brummelen P., Chang P.C., Vermeij P., van Zwieten P.A.: Arterial and venous effects of serotonin in the forearm of healthy subjects are not age-related. J. Cardiovasc. Pharmacol 14: 14–21, 1989.
Barringer D., Buñag R.D.: Differential anesthetic depression of chronotropic baroreflexes in rats. J. Cardiovasc. Pharmacol 15: 10–15, 1990.
Buñag R.D., Krizsan D., Eriksson L.: Mediation of reflex tachycardia becomes exclusively ß-adrenergic in old Fischer 344 rats. Mech. Ageing Dev. 52: 179–194, 1990.
Buñag R.D., Teravainen T., Eriksson L.: Enhanced sympathetic mediation of chronotropic baroreflexes in old Sprague-Dawley rats. Mech. Ageing Dev. 53: 195–208, 1990.
Bruning J.L., Kintz B.L.: Computational Handbook of Statistics. Scott Foresman and Co., Glenview, IL, 1987, pp. 18–109.
Duncan D.B.: Multiple range and multiple f tests. Biometrics 11: 1–42, 1955.
Saxena P.R., Villalón C.M.: Cardiovascular effects of serotonin agonists and antagonists. J. Cardiovasc. Pharmacol 15: S17–S34, 1990.
Widdop R.E., Verberne A.J., Louis W.J., Jarrott B.: The effect of ketanserin on cardiovascular reflexes in conscious normotensive and spontaneously hypertensive rats. Eur. J. Pharmacol 186: 17–28, 1990.
Smits J.F., van Essen H., Tijssen C.M., Struyker Boudier H.A.: Effects of ketanserin on hemodynamics and baroreflex effects in conscious spontaneously hypertensive rats. J. Cardiovasc. Pharmacol 10: 1–8, 1987.
Kalkman H., Timmermans P., Van Zwieten P.: Characterization of the antihypertensive properties of ketanserin (R41468) in rats. J. Pharmacol Exp. Ther. 222: 227–231, 1982.
Kalkman H.O., Engel G., Hoyer D.: Three distinct subtypes of serotonergic receptors mediate the triphasic blood pressure response to serotonin in rats. J. Hypertens. 2: 143–145, 1984.
Cohen M.L., Fuller R.W., Wiley S.: Evidence for 5-HT2 receptors mediating contraction in vascular smooth muscle. J. Pharmacol Exp. Ther. 21: 421–425, 1981.
McCall R.B., Patel B.N., Harris L.T.: Effects of serotonin1 and serotonin2 receptor agonists and antagonists on blood pressure, heart rate and sympathetic nerve activity. J. Pharmacol Exp. Ther. 242: 1152–1159, 1987.
Alper R.H.: Hemodynamic and renin responses to (±)-DOI, a selective 5-HT2 receptor agonist, in conscious rats. Eur. J. Pharmacol 175: 323–332, 1990.
Ireland S.J., Tyers M.B.: Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of rat isolated vagus nerve. Br. J. Pharmacol 90: 229–237, 1987.
Evans R.G., Ludbrook J., Michalicek J.: Characteristics of cardiovascular reflexes originating from 5-HT3 receptors in the heart and lungs of unanaesthetized rabbits. Clin. Exp. Pharmacol. Physiol 17: 665–679, 1990.
Cocks T.M., Angus J.A.: Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 305: 627–630, 1983.
Houston D.S., Vanhoutte P.M.: Comparison of serotonergic receptor subtypes on the smooth muscle and endothelium of the canine coronary artery. J. Pharmacol Exp. Ther. 244: 1–10, 1988.
Hongo K., Nakagomi T., Kassell N.F., Sasaki T., Lehman M., Vollmer D.G., Tsukahara T., Ogawa H., Torner J.: Effects of aging and hypertension on endothelium-dependent vascular relaxation in rat carotid artery. Stroke 19: 892–897, 1988.
Moritoki H., Hosoki E., Ishida Y.: Age-related decrease in endothelium-dependent dilator response to histamine in rat mesenteric artery. Eur. J. Pharmacol 126: 61–67, 1986.
Hynes M.R., Duckies S.P.: Effect of increasing age on the endothelium-mediated relaxation of rat blood vessels in vitro. J. Pharmacol Exp. Ther. 241: 387–392, 1987.
Buhler F.R., Amstein R., Fetkovska N.: Serotonin and preactivated platelets in essential hypertension. J. Cardiovasc. Pharmacol. 10: S32–S34, 1987.
Ketkovska N., Amstein R., Ferracin F., Regenass M., Buhler F.R., Pletscher A.: 5HT-kinetics and sensitivity of human blood platelets: variations with age, gender and platelet number. Thromb. Haemost. 60: 486–490, 1988.
Gleerup G., Persson B., Hedner T., Winther K.: Serotonin-induced platelet aggregation predicts the anti-hypertensive response to serotonin receptor antagonists. Eur. J. Clin. Pharmacol. 44: 121–125, 1993.
Itoh H., Alper R.H., Buñag R.D.: Baroreflex changes produced by serotonergic or catecholaminergic lesions in the rat nucleus tractus solitarius. J. Pharmacol Exp. Ther. 261: 225–233, 1992.
Itoh H., Buñag R.D.: Age-related reductions of reflex bradycardia in conscious rats by catecholaminergic nucleus tractus solitarius lesions. Mech. Ageing Dev. 67: 47–63, 1993.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Davidow, L.W., Schmitz, T.M. & Buñag, R.D. Aging enhances serotonergic cardiovascular blockade by ketanserin in conscious rats. Aging Clin Exp Res 6, 239–248 (1994). https://doi.org/10.1007/BF03324249
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03324249